Skip to main content

Table 3 Bivariate Analysis for Women.

From: Factors associated with improvement in disability-adjusted life years in patients with HIV/AIDS

VARIABLE

YLL

YLD

DALY

 

Mean (Stand. Dev.)

p-value

Mean (Stand. Dev.)

p-value

Mean (Stand. Dev.)

p-value

IVDU

   No

23.44 (27.34)

< 0.001

3.99 (3.88)

0.009

27.43 (25.39)

< 0.001

   Yes

29.46 (26.64)

 

4.58 (4.33)

 

34.03 (23.97)

 

Province of residence at diagnosis

   Jaen

22.44 (26.25)

0.126

4.78 (4.44)

0.347

27.22 (23.61)

0.027

   Huelva

30.22 (27.35)

0.252

4.51 (4.39)

0.704

34.73 (24.88)

0.186

   Almeria

26.97 (27.09)

0.948

4.44 (3.63)

0.723

31.42 (24.92)

0.902

   Cordoba

32.06 (26.84)

0.036

3.97 (4.60)

0.393

36.02 (23.96)

0.039

   Granada

18.58 (25.27)

< 0.001

5.06 (4.10)

0.020

23.63 (23.43)

< 0.001

   Cadiz

29.48 (27.02)

0.084

4.10 (4.24)

0.331

33.58 (24.63)

0.084

   Seville

25.14 (27.67)

0.333

4.75 (4.14)

0.111

29.89 (25.24)

0.424

   Malaga

28.00 (27.04)

0.300

3.91 (4.02)

0.014

31.91 (24.94)

0.469

Diagnosis Period

   Up to and including 1996

35.89 (26.40)

 

4.92 (4.89)

 

40.81 (22.47)

 

   1997 and 1998

16.57 (24.35)

< 0.001

5.47 (2.77)

0.127

22.04 (21.97)

< 0.001

   1999 onwards

12.77 (21.48)

< 0.001

2.53 (1.90)

< 0.001

15.31 (20.54)

< 0.001

  1. Qualitative Variables
  2. IVDU: Intravenous drug users
  3. YLL: Life lost due to premature mortality
  4. YLD: Years lost due to disability
  5. DALY: Disability-adjusted life years